Clinical trial Recruiting at 1 site Observational Ages 21 and up

Optimized MP MVA refractive technique for better visual performance

Official title: Clinical Evaluation of Visual Outcomes in LEAP, HIGH, COMP and VISN Extension Cohort

Run by Hoya Surgical Optics, Inc. · NCT07595432 · Data updated 2026-11-12

This study tests whether the optimized Maximum Plus Maximum Visual Acuity method helps people with prior IOL implants see better at intermediate distances.

Quick facts

Study typeObservational
Ages21 Years and up
SexAll
Enrollment140 (estimated)
SponsorHoya Surgical Optics, Inc.
Industry-sponsored
Locations1 site (Manila)
StatusRecruiting
StartedMay 13, 2026
Main results expectedNovember 30, 2026
Study endsNovember 30, 2026
Registry record updatedJune 4, 2026
Trial IDNCT07595432 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with prior intraocular lens implantation who meet the inclusion criteria and have clear media, able to consent, and participate in required visits.

Probably not a fit

Patients with corrected distance acuity worse than 0.2 logMAR (20/32) or those with conditions likely to affect outcomes may receive no demonstrated benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multicenter, non-interventional observational study that compares visual outcomes between two sites while masking examiners. It includes patients previously enrolled in Hoya studies or previously implanted with non-toric monofocal IOLs, focusing on distance-corrected intermediate visual acuity. The study aims to demonstrate non-inferiority of mean DCIVA between Site 1 and Site 2. Participation does not involve an active treatment, and data are collected from existing IOL recipients during routine follow-up visits. The design supports exploratory sub-analysis for eyes with specific prior IOL histories.

Why it matters

Potential benefit: If successful, the findings could support the use of the optimized MP MVA technique to maintain or improve intermediate vision in patients with prior IOL implants.

How similar studies have gone: Prior studies in this area have shown mixed results, with some demonstrating non-inferiority or comparable outcomes in similar refractive assessments.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Main study:

1. Previously implanted with intraocular lens through 2 previous IOL studies;
2. Clear intraocular media with no clinically significant opacity, in the investigator's judgment, that would affect visual acuity;
3. Able to provide informed consent and complete all required study procedures.

Exploratory sub-study:

1\. Additional inclusion criteria: Pseudophakic eyes implanted with one of the IOLs in one eye from 3 previous IOL studies

Exclusion Criteria:

Main study:

1. Corrected distance visual acuity (CDVA) worse than 0.2 logMAR (or 20/32 Snellen)
2. Subjects with ongoing medical conditions or treatment that might impact outcomes during the study visit as determined by the investigator.

Exploratory sub-study:

1\. Additional exclusion criteria: Pseudophakic eyes with oblique residual astigmatism.

Where it's running

  • Peregrine Eye Laser Institute
    Manila, Philippines
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.